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Dear Home Secretary,  
Re: ACMD report on Custody-Community Transitions (CCT)   
The Advisory Council on the Misuse of Drugs (ACMD) has taken notice of emerging 
evidence on the increasing drug-related harms in prisons and related to transitions through 
the criminal justice system. In particular, the increased risk of death, including by overdose, 
in the weeks immediately following release to the community. 
Previous reports by other experts in this field, including the group led by Lord Patel in 2010, 
had made recommendations to improve continuity of care. However, the extent to which 
these have been implemented across government is unclear. The ACMD sought to 
determine the most important existing recommendations and to what extent these had been 
implemented, and whether there was a need for new or adapted recommendations. 
The ACMD invited stakeholders from government departments, service providers, and 
charities, amongst others, to submit evidence to the inquiry. The ACMD examined the 
evidence and identified substantial harms associated with transitions by people who have 
drug-related problems, including: 
• High incidence of homelessness. Many prisoners under supervision from the 
National Probation Service or Community Rehabilitation Companies are discharged 
to unsettled or unknown accommodation on their first night of release. This increases 
the risk of relapse and reoffending. 
• Adults serving sentences of less than 12 months in England and Wales had a 
reoffending rate of 64.4% between April and June 2017, with rates likely to be even 
higher among those with a drug problem. 
• Increased risk of death. Death rates among those on post-release supervision, are 
many times higher than in the general population. The first few weeks immediately 
following release to the community is the highest risk period. 
• Custody as an opportunity to reduce drug problems and offending was often 
squandered by failure to provide support on release. 
 
There has also been a lack of systematic follow-up on and the fragmentation of responsibility 
for implementing previous recommendations. Previous reports had highlighted continuity of 
care as being critical. However, the latest data from PHE suggest that only 32.1% of people 
assessed as needing treatment when they leave prison enter treatment in the community 
within 21 days of release. 
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Equivalence of care between custody and the community has also been stated as important. 
Current policy outside prisons is to maximise access to naloxone (the medicine that reverses 
opioid overdose). Despite this, only 12% of prisoners who were previously heroin-dependent 
left an English prison with naloxone in 2017/18. 
The ACMD makes the following recommendations for systemic improvement for 
transitions between custody to community:  
1. That the Drug Strategy Board nominates one Minister who will have over-arching 
responsibility and accountability for the improvement of custody-community 
transitions for prisoners with complex health needs, including problems with drugs. 
2. That this Minister be given the following mandate: To assess and improve 
performance in delivering officially accepted recommendations on transitions 
between custody and the community for people with substance misuse, mental 
health and homelessness problems. The indicators of progress in this area should 
include the following. 
a. Reducing the rate of reoffending (within six months and after two years) of 
people who leave prison and who have an assessed need for drug treatment. 
b. Reducing the numbers of people who die within four weeks of leaving custody 
(separated by police and prison custody) and while under the supervision of 
the probation services. These data should be collated separately for suicides 
and drug-related deaths, following the definitions that the Office for National 
Statistics uses for the general population. 
c. Reducing the proportion of people who leave prison with unsettled or 
unknown accommodation on the first night of release. 
d. Increasing the proportion of people who have an assessed need for drug 
treatment on release who enter treatment in the community within four weeks 
of release. 
e. Increasing the proportion of prisoners who are assessed as having a problem 
with opioids who leave prison with naloxone. 
3. That the Minister of Justice (England and Wales), the Cabinet Secretary for Justice 
(Scotland) and their counterpart in Northern Ireland take further steps to reduce the 
number of transitions into and out of prisons. This includes reducing the use of short 
prison sentences of less than 12 months and the number of people who are recalled 
to prison. This should involve: 
a. reform sentencing to minimise the use of sentences of less than 12 months, 
with the aim of eliminating the use in sentencing of periods of less than 3 
months in prison; and 
b. reforms to the system of supervision on licence, so as to reduce the number 
of people who are recalled to prison. 
We also make the following practical recommendations to reduce harms: 
4. That the prison services of the UK take steps to minimise the release of prisoners 
with complex needs (including substance misuse) on Friday afternoons. 
5. That the Department for Work and Pensions (DWP) should: 
a. accelerate the introduction of the measures listed in the Rough Sleeping 
Strategy (MHCLG, 2018) to enable prisoners to access employment or 
Universal Credit immediately on release; and  
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b. work in partnership with the courts and the National Probation Service (NPS) 
to ensure that people who are imprisoned are not overpaid the housing 
element of Universal Credit. 
c. Following the completion of the evaluation of the pilots, implement the 
effective elements identified through evaluation  
6. That the prison and probation services of the UK should develop and extend services 
that provide face-to-face, individualised support to prisoners who have drug problems 
in the run up to release and through the transition to the community.  
7. That the Drug Strategy Board should make a clear statement that it is the 
responsibility of the national NHS bodies to ensure that all people who have an 
assessed problem with opioid use should be given the opportunity to take home 
naloxone when they leave prison or police custody. The Board should ensure that 
resources are made available to the national NHS bodies to support this 
responsibility. 
8. That relevant agencies (for example, PHE) establish custody-community pathways 
into identified treatment for prisoners who have an assessed problem with alcohol, 
cannabis, cocaine, or other non-opioid drugs – as well as for users of opioids. 
Additionally, that a pathway should be developed that offers sufficient support to 
enable prisoners leaving abstinence-focused interventions to maintain such change 
following release. 
9. That the Home Office should commission research specifically to identify and 
ameliorate problems and opportunities related to transitions into and out of police 
custody by people who have problems with drugs. This should include gathering 
information, across the UK, on: 
a. the levels of overdose and drug-related deaths in police custody and 
immediately afterwards; and, 
b. the coverage and effectiveness of Liaison and Diversion schemes in meeting 
the needs of arrestees with drug and alcohol misuse problems. 
 
We welcome the opportunity to discuss and present this report to the Drug Strategy Board.   
 





Dr Owen Bowden-Jones   Professor Alex Stevens 
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This report from the Advisory Council on the Misuse of Drugs (ACMD) provides advice on how to 
reduce drug-related harms that occur when people move between custody and the community. It 
seeks to answer three questions. 
1. What are the drug-related harms and benefits associated with transitions between custody and 
the community? 
2. What are the most important existing recommendations in this area, and to what extent have 
they been implemented? 
3. Is there a need for new or adapted recommendations? 
 
This report was written by the Custody-Community Transitions working group, chaired by Professor 
Alex Stevens. It is based on previous reports and evidence gathered by invitation of written 
submissions and an evidence-gathering day. 
The report identifies substantial harms associated with transitions between custody and the 
community, especially for people who have problems with drugs, including the following. 
• Homelessness. In 2017/18, 34.5% of adult prisoners under supervision from the National 
Probation Service or Community Rehabilitation Companies were discharged to unsettled or 
unknown accommodation on their first night of release (MoJ, 2018a). 
• Reoffending. Adults serving sentences of less than 12 months in England and Wales had a 
reoffending rate of 64.4% between April and June 2017, with rates likely to be even higher 
among those with a drug problem. 
• Transmission of blood-borne viruses. Prison is a risk environment for the transmission of HIV 
and Hepatitis C (Dolan et al., 2016), so entry to prison can be a risk for infection, and release 
may spread that risk to the community. However, the prevalence of HIV infection among 
prisoners is low by international standards (Golrokhi et al., 2018). 
• Increased risk of death, including by overdose. Death rates among prisoners and, especially, 
those on post-release supervision are many times higher than in the general population. The 
few weeks immediately after release is a particularly high risk period for drug-related death  
(Inquest contribution, 2018; also House of Commons Health and Social Care Select 
Committee, 2018; Phillips et al., 2017; Graham et al., 2015). 
For some people, entering the criminal justice system can provide an opportunity to reduce drug 
misuse and enter treatment. However, these benefits are too often squandered by the failure to 
provide continuity of care between custody and the community (Lloyd et al., 2017). 
 
This report identified a number of important previous reports and recommendations that have been 
made on this issue (see Appendix 2), including: 
• Bradley (2009) The Bradley Report: Lord Bradley’s Review of people with mental health 
problems or learning disabilities in the criminal justice system (the Bradley review); and,  
• Patel (2010) The Patel Report: Reducing Drug-Related Crime and Rehabilitating Offenders: 





These reports have not been systematically followed up, so it is difficult to know the extent to which 
they have been implemented. There are, however, concerning indicators of failure to implement 
previous recommendations, including the following. 
• On continuity of care: Patel (2010) identified this as the key element in reducing drug-
related problems for people leaving prison. However, the latest data from Public Health 
England (PHE) suggest that only 32.1% of people who are assessed as needing treatment 
when they leave prison enter treatment in the community within 21 days (PHE, 2018a).  
 
• On equivalence of care: Bradley (2009) endorsed the principle of equivalence of healthcare 
between custody and community. Current policy outside prisons is to maximise access to 
naloxone (the medicine that reverses opioid overdose). However, only 12% of prisoners who 
were previously heroin-dependent left an English prison with naloxone in 2017/18 (PHE, 
2019). In Scotland, 664 take-home naloxone (THN) kits were issued in 2017/18, to 
approximately 35% of the prisoners who tested positive for opioids at reception (ISD, 
2018a). 
 
• On reoffending. The aim of the Transforming Rehabilitation White Paper (MoJ, 2013) was to 
reduce reoffending rates. However, the performance of Community Rehabilitation 
Companies in providing these services has been widely criticised and they have failed to 
reduce high rates of reoffending, especially among short-term prisoners. The quality of 
probation services in England has been diminished (Stacey, 2019). This has particularly 
worrying implications for people with drug problems, who are in need of additional and 
specialist support. 
In order to facilitate the implementation of existing and future recommendations, this report makes 
the following recommendations for systemic improvement. 
1. That the Drug Strategy Board nominates one Minister who will have over-arching 
responsibility and accountability for the improvement of custody-community transitions for 
prisoners with complex health needs, including problems with drugs. 
2. That this Minister be given the following mandate: To assess and improve performance in 
delivering officially accepted recommendations on transitions between custody and the 
community for people with substance misuse, mental health and homelessness problems. 
3. That the Minister of Justice (England and Wales), the Cabinet Secretary for Justice (Scotland) 
and their counterpart in Northern Ireland take further steps to reduce the number of 
transitions into and out of prisons, especially as multiple short sentences are associated with 
increased risk of death. This should involve: 
a. reform sentencing to minimise the use of sentences of less than 12 months, with the 
aim of eliminating the use in sentencing of periods of less than 3 months in prison; 
and 
b. reforms to the system of supervision on licence, so as to reduce the number of 
people who are recalled to prison. 
 
This report also makes the following practical recommendations. 
4. That the prison services of the UK take steps to minimise the release of prisoners with 
complex needs (including substance misuse) on Friday afternoons. 
5. That the Department for Work and Pensions (DWP) should: 
 8 
 
a. accelerate the introduction of the measures listed in the Rough Sleeping Strategy 
(MHCLG, 2018) to enable prisoners to access employment or Universal Credit 
immediately on release; 
b. work in partnership with Her Majesty’s Courts and Tribunal Services (HMCTS) and 
the National Probation Service (NPS) to ensure that people who are imprisoned are 
not overpaid the housing element of Universal Credit; and, 
c. Following the completion of the evaluation of the pilots, implement the effective 
elements identified through evaluation. 
6. That the prison and probation services of the UK should develop and extend services that 
provide face-to-face, individualised support to prisoners who have drug problems in the run 
up to release and through the transition to the community.  
7. That the Drug Strategy Board should make a clear statement that it is the responsibility of 
the national NHS bodies to ensure that all people who have an assessed problem with opioid 
use should be given the opportunity to take home naloxone when they leave prison or police 
custody. The Board should ensure that resources are made available to the national NHS 
bodies to support this responsibility. 
8. That relevant agencies (for example, PHE) establish custody-community pathways into 
identified treatment for prisoners who have an assessed problem with alcohol, cannabis, 
cocaine, or other non-opioid drugs – as well as for users of opioids. Additionally, that a 
pathway should be developed that offers sufficient support to enable prisoners leaving 
abstinence-focused interventions to maintain such change following release. 
9. That the Home Office should commission research specifically to identify and ameliorate 
problems and opportunities related to transitions into and out of police custody by people 
who have problems with drugs. This should include gathering information, across the UK, on: 
a. the levels of overdose and drug-related deaths in police custody and immediately 
afterwards; and, 
b. the coverage and effectiveness of Liaison and Diversion schemes in meeting the 
needs of arrestees with drug and alcohol misuse problems. 
 
Introduction 
There are currently several government cross-departmental commitments related to custody-
community transitions. The Drug Strategy (2017) committed to ‘looking at how to move to a joint 
approach to commissioning of health services, including drug and alcohol treatment, in prisons. This 
aims to give governors more control and accountability over the services and treatments in their 
prison, and ensure continuity of treatment with services in the community’ (HM Government, 2017).  
In 2017, the Advisory Council on the Misuse of Drugs (ACMD) established a working group to report 
on drug-related harms and benefits related to transitions between custody and the community. This 
followed concerns among members of the Council about increasing harms related to drug misuse as 
people move through the criminal justice system.  
In 2018, Public Health England (PHE) published its guidance for improving continuity of care between 
prison and the community, which states that continuity of care is a priority for government (PHE, 
2018c).   
The recently published Prisons Drug Strategy (MoJ, 2019b) outlined its aims to:  
 9 
 
• reduce the number of drug-related deaths in custody;  
• increase the proportion of those prisoners who complete treatment who do not return 
within six months, by December 2020; and, 
• increase the proportion of prisoners with substance misuse treatment needs who are 
successfully engaged in community-based treatment within 21 days of release from prison, 
by December 2020.  
The Home Secretary’s work programme commission (2017-2019) also requested the ACMD’s advice 
on the following question:  
How can the criminal justice and healthcare systems' responses at charging, sentencing, 
imprisonment and release be made more effective in responding to offenders' drug misuse and its 
impact on their health and risk of offending?  
 
This report is intended for the Home Secretary and other relevant ministers, including the Minister 
for Justice and the Minister for Health and Social Care and their counterparts in Scotland and 
Northern Ireland. It will also be of use to other health and criminal justice agencies. It should be read 
in conjunction with previous ACMD reports, including the 2016 report on Reducing opioid-related 
deaths in the UK and the upcoming report on Drug-related harms in homeless populations and how 
they can be reduced, which also considers the housing needs of people released from prison. 
The three questions that this inquiry set out to answer are listed below. 
1. What are the drug-related harms and benefits associated with transitions between custody 
and the community? 
2. What are the most important existing recommendations in this area, and to what extent 
have they been implemented? 
3. Is there a need for new or adapted recommendations? 
 
The focus of the report is on adults only. Custodial settings considered in this report include police 
stations and prisons in all four countries of the UK.1 
 
The evidence underpinning this report was collected using the following methods. 
• A review of existing recommendations in the field. 
• Gathering information on the current state of implementation of these recommendations 
through: 
o consulting agencies in the field (see Appendix 1); 
o inviting written submissions from these agencies and others, through an open call 
for evidence; 
o a public evidence-gathering day held in June 2017; and, 
o further discussion with members of the Custody-Community Transitions working 
group.  
The report is structured to follow the three questions that the inquiry set out to answer. 
                                                          
1 This report has not looked at issues related to immigration detention. There was far less information on 
police custody than was available on prison custody.  
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Drug-related harms and benefits associated with custody-community 
transitions 
Crime suspects and detainees, especially those who have problems with drugs, form a diverse and 
highly complicated group. They have a range of complex needs, often including trauma brought on 
by adverse childhood experiences, learning disabilities, lack of family support, mental and physical 
health problems, insecure housing as well as problems with alcohol and other substances (ACMD, 
2018). The levels of all these problems are considerably higher among prisoners than in the general 
population (Revolving Doors, 2013). It has long been accepted that imprisonment is an environment 
of heightened risk of problems related to drug use, creating a need for specific interventions to 
reduce drug-related harms (Stevens, Stöver, & Brentari, 2010; Strang, 1993). The overlapping issues 
of substance misuse, homelessness and mental health among the prison population make it difficult 
to address one without addressing the others. All have an impact on drug-related harms in the 
custody-community transitions. 
 
These transitions often create additional risks (Denton, Foster, & Bland, 2017). Both entering and 
leaving custody can exacerbate drug-related and other problems. Some common risks encountered 
in custody-community transitions are listed below. 
• Create or worsen problems with housing. In 2017/18, 34.5% of adult prisoners under 
supervision from the National Probation Service (NPS) or Community Rehabilitation 
Companies (CRCs, excluding London)2 were released to unsettled or unknown 
accommodation on their first night (MoJ, 2018a).3 In Wales, this problem was exacerbated 
by removing housing priority for released prisoners in 2014.4 
• Be swiftly followed by reoffending and re-imprisonment. Adults serving sentences of less 
than 12 months in England and Wales had a proven reoffending rate of 64.4% between April 
and June 2017 (MoJ, 2019a). 
• Increase the risk of acquiring a blood-borne virus (BBV) and of interrupting treatment for HIV 
or viral hepatitis (SPS, 2012; Rumble et al., 2015; Dolan et al., 2016). Prison systems in the 
UK have prevented further outbreaks of HIV within prisons and offer opt-out testing for 
BBVs. Prevalence of HIV infection among prisoners is low by international standards 
(Golrokhi et al., 2018). However, failure to provide continuity of care for people who have 
HIV or viral hepatitis as they transition into the community increases risks of disease 
progression and transmission. 
• Lead to an increased risk of death. Death rates among prisoners and, especially, those on 
post-release supervision are many times higher than in the general population. There were 
955 deaths of offenders in the community in England and Wales in 2017/18 (MoJ, 2018b). 
The few weeks immediately after release is a particularly high-risk period for drug-related 
death. In 2017, the number of opioid-related deaths within four weeks of prison release was 
31 (ISD, 2018b). There is an increased mortality risk associated for people who serve 
multiple short sentences (Inquest contribution, 2018; also House of Commons Health and 
Social Care Select Committee, 2018; Phillips et al., 2017; Graham et al., 2015). 
• Lead to a rapid return to previous drug-taking behaviours, compromising any benefits of 
prison treatment (Lloyd et al., 2017). 
                                                          
2 Reliable figures were not available for London. 
3 The Patel report (Patel, 2010) noted the importance of stable housing. It concluded that there was “a very 
clearly articulated need for much greater support and help on release especially with respect to appropriate 
housing, having enough money, having something meaningful to do, and greater integration and co-ordination 
with community services”. 




There is a particular problem for people released from custody who use opioids (for example, 
heroin). Restricted access to heroin while in custody can reduce physical tolerance to these 
substances. If these people then relapse to drug use on release, they face a heightened risk of dying 
by overdose. Such relapses and deaths are particularly likely when people are released without 
access to housing or drug treatment (Farrell & Marsden, 2008; National Treatment Agency, 2012; 
Marsden et al., 2017).  
 
The range of needs can be especially complex for particular groups of people in the criminal justice 
system. This includes women, older service users, members of black and ethnic minorities, members 
of gypsy and traveller communities, and people who have transgender identity. The criminal justice 
system works with a majority of white, male, heterosexual people of a relatively young age. It is 
often difficult for this system to adapt to the specific needs of people who are not in this majority 
(Patel, 2010).  
 
The entry to custody (via arrest or imprisonment) provides an opportunity to take steps that reduce 
crime and health harms for arrested people, victims and the wider society. Release from custody is a 
key point for securing these potential benefits. It is often observed that improvements in health and 
in factors related to reoffending are not maintained on release from custody (ibid.). 
 
This signals a broader need to distinguish between the transitions and treatment of individuals on 
the basis of ‘recovery capital’ – the social and personal resources needed to enact and sustain 
change (see, for example, Best & Laudet, 2010; ACMD, 2013). Those with fewer resources and long 
histories of opioid misuse may benefit particularly from maintained opioid prescriptions and re-
engagement with community prescribers following release (ACMD, 2015; Lloyd et al., 2017, pp 16–
17). Those with higher levels of recovery capital, and alcohol, cannabis or cocaine dependence 
(rather than opioid dependence) may be better-placed to engage with abstinence-focused services 
in prison (ACMD, 2013; Page et al., 2016), though hitherto their subsequent pathway into 
community support and the nature of community treatment has been less clearly described in policy 
or research. However, the forthcoming report from the Ex-Prisoners Recovering from Addiction 
(EPRA) working group, chaired by Lord Patel will outline four ‘blueprint’ pathways for abstinence-
focused through-care, divided by sentence length and gender.5  
 
In the last ten years, a new challenge has emerged in the form of synthetic cannabinoid receptor 
agonists, which are often referred to as ‘Spice’ (Ralphs, et al., 2017; User Voice, 2016). These have 
exacerbated problems in prisons around safety, security and health (CJJI, 2017). Prisoners reported 
that the main reasons for taking synthetic cannabinoids in prison were ease of access, avoidance of 
drug testing for other substances, and boredom (User Voice, 2016). Action is already being taken by 
the Ministry of Justice (MoJ) in the ’10 prisons project’. However, the Custody-Community 
Transitions working group learned from Manchester Metropolitan University (MMU) that some 
interventions have worsened problems related to synthetic cannabinoids. The programme of 
mandatory drug testing in prisons and the extension of testing on licence may have encouraged 
prisoners to move to the use of synthetic cannabinoids (which are less often detected in commonly 
applied drug tests) instead of cannabis, which is usually less harmful (Ralphs et al., 2017). Some 
synthetic substances were added to the panel of drugs that mandatory drug tests can detect in 
September 2016. The criminalisation of the possession of recently developed synthetic cannabinoids 
in custody through the Psychoactive Substances Act 2016 and the subsequent classification of these 
‘third generation’ synthetic cannabinoids under the Misuse of Drugs Act 1971 did not appear to 
reduce the problems related to these substances in prison (Home Office, 2018). 
 
                                                          
5 Please contact Charlie Lloyd at the University of York for details (charlie.lloyd@york.ac.uk). 
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Issues around synthetic cannabinoids that are particularly related to custody-community transitions 
include the following (MMU contribution, 2018). 
• The frequent movement of people on short sentences or prison recall from the community 
into custody facilitates the supply of synthetic cannabinoids in prison.  
• It is reported that many people begin or deepen a problem with the misuse of synthetic 
cannabinoids after entering prison, and may continue these problems on release (see also 
Lloyd et al., 2017).  
• The additional problems caused by the use of synthetic cannabinoids in prison can inhibit 
effective rehabilitation and resettlement planning. This is because resources are often 
drawn away from rehabilitation-focused activities to deal with cannabinoid-related 
emergencies. It is also because the use of synthetic cannabinoids can inhibit individual 
prisoners’ engagement in pre-release planning. 
 
The impact on families of people moving between custody and community can be very damaging. 
The working group heard from Adfam about the trauma, shame and sense of loss experienced by 
families whose loved ones enter prison (Condry & Smith, 2018). Particularly for people with drug 
problems, families very often struggle to find help in dealing with these problems. The imprisonment 
of a family member can lead to financial difficulties through loss of family income and the cost of 
visiting prisons, especially for families in less densely populated areas who often have to travel very 
long distances to visit a prisoner. Families may also feel obliged to house or support ex-prisoners 
following their release, even when this exposes them to exceptional stress and a real risk of 
victimisation (Lloyd et al., 2017, pp 207–209). 
 
These difficulties are particularly acute for families where the imprisoned person has parental 
responsibilities. In the majority of cases, this is a woman. Women’s prisons are fewer and further 
between, exacerbating the difficulty of maintaining family contacts. There is a new government 
Female Offender Strategy (MoJ, 2018c). However, the (2007) recommendations of Baroness 
Corston’s review, which called for “a distinct, radically different, visibly-led, strategic, proportionate, 
holistic, woman-centred, integrated approach” have not been fully implemented (Corston, 2007; 
also Changing Lives contribution, 2018; Release contribution, 2018). 
 
As many organisations and experts have observed (Collective Voice contribution, 2018; Blenheim 
contribution, 2018; Release contribution, 2018), the working group was told repeatedly by 
stakeholders in the field that the reduction of resources spent on prisons since 2010 – while not 
reducing the prison population – had substantially reduced security and safety in prisons. It had also 
damaged the ability of prisons to provide effective rehabilitation and resettlement planning (for 
example, Lloyd et al., 2017, pp 95–96).  
 
This has been compounded by changes to English and Welsh probation services in 2014 that, it was 
widely predicted, would reduce their effectiveness (for example, Ludlow, 2014). The splitting of 
provision between the NPS and CRCs has reduced effective partnership working (Collective Voice 
contribution, 2018). The idea that CRCs would provide ‘through the gate’ services to help to resettle 
prisoners on release has not been implemented in practice (for example CJJI, 2016; CJJI, 2017). The 
extension of provision of CRC services to prisoners released from sentences shorter than 12 months 
has increased the number of people on post-sentence supervision (CJJI, 2016; House of Commons 
Justice Select Committee, 2018). However, CRCs have struggled both to provide adequate 
supervision to their service users (as individual probation officers’ caseloads have risen) and to make 
the financial model work (as CRCs received fewer cases than anticipated) (House of Commons 
Justice Select Committee, 2018). The number of people who die while under such supervision has 
increased much faster than the caseload (Inquest contribution, 2018). The number of deaths in 
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England and Wales was 955 in 2017/18, compared to 560 in 2013/14, an increase of 71%. In the 
same period, the caseload of offenders supervised in the community increased by 18% (MoJ, 2019c). 
The operating model for probation services is currently being revised by the MoJ. It should include 
measures to reduce these deaths, as well as to reduce reoffending. 
 
There is an opportunity to create benefits for service users and society if transitions between 
custody and community are handled well. A small proportion of people who offend repeatedly 
commit large proportions of crime. For example, in 2009/10, 49,000 adults were identified as 
offenders with drug misuse problems. They represented 8.7% of adult offenders but committed 
26.8% of proven reoffending by adults (MoJ, 2012, page 18).6 Relapse to Class A drug use on release 
is associated with an increase in the odds of proven reoffending of over 50% (Brunton-Smith & 
Hopkins, 2013). This prolifically reoffending group tends to experience multiple, short periods of 
custody. They also experience serious health harms, including highly elevated rates of death on 
release (Farrell & Marsden, 2008). It is vital that ministers improve the way that agencies within and 
around the criminal justice system work to reduce the offending and drug use of individuals who are 
currently enmeshed in such patterns of behaviour, and to support and divert those who may be at 
risk of becoming serial reoffenders. 
Previous recommendations 
In developing this work, there are many previous recommendations on which ministers and officials 
can draw upon (see Appendix 2). The Custody-Community Transitions working group considered two 
reports to be particularly important. The first was Lord Bradley’s (2009) Review of people with 
mental health problems or learning disabilities in the criminal justice system (the Bradley review). 
The second was Lord Patel’s (2010) report on Reducing Drug-Related Crime and Rehabilitating 
Offenders (the Patel report). 
 
The key themes that run through these and other reports (listed in Appendix 2) in the field are as 
follows. 
• That the biggest challenge, and the greatest missed opportunity for reducing reoffending 
and improving health, is the absence of continuity of care for people who enter and leave 
custody with complex needs. 
• That healthcare provided to people in the criminal justice system should be at least 
equivalent to that provided in the community. 
• Co-morbidity between mental health problems and drug misuse (‘dual diagnosis’) in prisons 
is prevalent. There needs to be more clearly defined mechanisms for managing patients with 
dual diagnosis, formal links between mental health and drug treatment provision, and 
greater awareness among staff.  
• The need for a cohesive, inter-departmental strategy on drug misuse in prison is often 
raised. Fragmentation between different services and conflict between different 
organisations’ targets was identified as a problem that leads to inconsistency in care and 
inefficiencies.  
• Services should be more integrated. The criminal justice system should coordinate with 
healthcare providers, mental health services, and community supports to ensure that people 
are given continuity of care in the vulnerable weeks following release. It is often noted that 
individuals should be involved in pre-release planning and should be put in contact with 
support and treatment options in the community quickly after leaving prisons. 
                                                          
6 Research from Uruguay suggests that there may be an increase in crime on days when more prisoners are 




• Treatments that help people with drug problems to accrue recovery capital – which includes 
social relationships, health, skills and aspirations, as well as employment and housing – are 
identified as valuable to sustained recovery. It is often recommended that local housing and 
employment organisations are also integrated into the resettlement process. 
• The benefits of mutual aid to recovery are often highlighted. Support groups are linked to 
improved treatment outcomes, and it is suggested that actively guiding people towards 
these groups improved engagement.  
• Ensuring access to services and support is consistent across the country, as adapted to local 
needs. The difficulty of securing continuity of care for people who are imprisoned far from 
their homes is frequently mentioned. 
• Data collection should be developed, and different organisations should share information 
where possible to reduce inefficiency, identify areas for improvement and highlight gaps in 
service provision. 
• There should be a national framework for continual improvement of services by setting clear 
performance outcomes and analysing local needs and evidence of what works.  
Implementation of previous recommendations 
One of the main findings of this inquiry is that it is very difficult to assess the extent to which 
previous recommendations in the field have been implemented. This is due, among other causes, to 
the following. 
• Lack of systematic follow up  
 
Recommendations and strategies have often been made without a process for generating 
information that will feed into subsequent improvements. For example, there has been:  
o no official report on the implementation of the recommendations of the Patel 
report;  
o no evaluation of the impact of transferring responsibility for prison healthcare to the 
NHS in England; and,  
o no official assessment of the effect of the Health and Social Care Act 2012 on the 
provision and continuity of drug treatment in the criminal justice system.  
There are apparently plans to assess the implementation of the Bradley review, but this has 
not yet started, and there have been no regular progress reviews.  
 
• Fragmentation of responsibility for implementing recommendations  
 
Many of the strategies discussed in this report have their own multi-agency governance 
boards. However, as the House of Commons Health and Social Care Select Committee (2018) 
also recently noted, who owns responsibility for making specific improvements is very often 
unclear. If, as this Committee recommended, the Government is to develop a ‘whole system’ 
approach to improving outcomes in and out of the criminal justice system, then clear lines of 
responsibility and accountability for managing this systemic approach need to be put in 
place. 
 
In some parts of the system, responsibility for implementing previous recommendations has 
been placed at levels that are not senior enough to make the necessary changes. For 
example, the Rough Sleeping Strategy (MHCLG, 2018) places responsibility on prison 
governors to work with the NPS and CRCs to reduce the number of prisoners who are 
released without settled accommodation. However, neither prison governors nor the NPS or 




• The absence of systematically collected data 
 
The Government’s drug strategy evaluation (HM Government, 2017) identified substantial 
gaps in knowledge on the effects of drug policy. The Government decided not to implement 
previous Advisory Council on the Misuse of Drugs (ACMD) recommendations to enhance 
research capacity (ACMD, 2016a; 2016b). It is therefore difficult for ministers and officials to 
know the extent to which previous recommendations and strategies have succeeded in 
improving processes and outcomes. 
 
Much relevant information is collected. For example, PHE collects data on the proportion of 
people who are released from prison with an assessed need for drug treatment and who 
enter treatment in the community within 21 days. This forms part of the Public Health 
Outcomes Framework (PHE, 2018a). However, many other relevant indicators are not 
collected or collated (see list in recommendation number 2 below). An important example is 
that there are no nationally reported data on the number of people who die within the first 
few weeks of release from prison.7 This information is reported in Scotland (Graham et al., 
2015). 
 
There is a particular lack of collection of information from the perspective of people who go 
through the transition between custody and the community. Service user involvement in 
creating and communicating this information would help to improve services. 
It should be noted that there have been more systematic efforts to follow up recommendations and 
strategies in Scotland than in England. An example is the Royal College of Nursing Scotland’s 2016 
report Five Years On, which assessed progress since the NHS took over responsibility for prison 
healthcare. In 2017, the Scottish Parliament’s Health and Sport Committee wrote a report on 
healthcare in prisons. This was followed by the Scottish Government’s establishment of the Health 
and Justice Collaboration Improvement Board. This plays a broader role across the criminal justice 
system than the Westminster-based National Prison Health Board. The Scottish drug and alcohol 
strategy (Scottish Government, 2018b), its justice strategy (Scottish Government, 2012) and its 
community justice strategy (Scottish Government, 2016) all include relevant plans, and a Quality 
Outcome and Improvement dashboard is being developed through the Scottish prison health and 
care programme.8 
 
There are, however, important recent developments in England. One is the 2016 NHS Health and 
Justice Strategy, which applies to NHS services across various justice settings. Another is the 2018-
2021 National Partnership Agreement for Prison Healthcare in England. This agreement brings 
together the MoJ, Her Majesty’s Prison and Probation Service (HMPPS), PHE, the Department of 
Health and Social Care (DHSC), and NHS England in working towards common objectives. The ACMD 
supports its aims, especially as they relate to reducing reoffending and enhancing continuity of care 
for people who have problems with drugs. The 2018 publication of PHE’s Guidance for improving 
continuity of care between prison and the community will be important in achieving these aims (PHE, 
2018c). This document includes several recommendations for improving continuity of care, in line 
with the emphasis of the Patel report (Patel, 2010) on this issue. 
 
                                                          
7 The available data show a concurringly high number of deaths among offenders under post-release 
supervision in England and Wales (MoJ, 2018b), but the number of drug-related deaths that occur among 
released prisoners in the highest risk period (i.e. the first four weeks) is not publicly reported. 
8 https://www.gov.scot/groups/health-and-justice-collaboration-improvement-board/  
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Despite the difficulty in assessing implementation, some concerning trends are visible in the data 
that are available.  
• Continuity of care. The Patel report stated that the key issue to address was the continuity of 
care between prison and the community. However, the latest data from PHE (2017/18) 
suggest that only 32.1% of people who are assessed as needing treatment when they leave 
prison enter treatment in the community within 21 days (PHE, 2018a).  
• Equivalence of care. The Bradley review (Bradley, 2009) endorsed the principle of 
equivalence of health between custody and the community. The current guidelines on 
clinical management of people with substance misuse problems (DHSC, 2017) states that 
previously heroin-dependent prisoners should be provided with a supply of THN on release 
from prison and that commissioners should support the provision of naloxone and overdose 
training in the community. However, only 12% of prisoners who were previously heroin-
dependent left English prison with naloxone in 2017/18 (PHE, 2019), and approximately 35% 
in Scotland (ISD, 2018a). 
• Reoffending. The aim of the Transforming Rehabilitation White Paper (MoJ, 2013) was to 
reduce reoffending rates. This was partly to be achieved by providing more support to 
prisoners released from sentences of less than 12 months, and an expansion of ‘through the 
gate’ services. However, the performance of CRCs in providing these services has been 
widely criticised (Collective Voice contribution, 2018; also House of Commons Justice Select 
Committee, 2018; (Stacey, 2019). Her Majesty’s Inspectorate of Probation recently 
commented on serious shortcomings in supervision of short-term prisoners on release, with 
no evidence that expanding post-release supervision to this group reduced their reoffending 
(HMI Probation, 2019). 
Nevertheless, substantial progress has been made in the last 20 years in reducing crime and 
protecting health in prisons. This includes improved arrangements for assessment and treatment of 
drug dependence at entry to custody, greater provision of evidence-based treatment for drug 
dependence (including opioid substitution therapy) in prison, and – more recently – a greater focus 
on supporting recovery in prisons, including investment in the pilot of drug recovery wings and the 
Drug Recovery Prison pilot at Her Majesty’s Prison (HMP) Holme House (Lloyd et al., 2017).9 
From the 1990s onwards, connections to drug treatment were created – primarily for opioid users – 
through arrest referral schemes, the Criminal Justice Interventions Teams and the Drug 
Interventions Programme (DIP) in England and a rising number of Drug Treatment and Testing 
Orders in Scotland. The benefits of these initiatives for people with histories of alcohol and non-
opioid drug use have not been clearly established. Since central funding for DIP was stopped in 2013, 
these services have been scaled back. However, NHS Liaison and Diversion schemes now cover 92% 
of the population of England. These schemes have the potential to provide support around both 
mental health and substance misuse problems, but the extent to which they are doing so is not yet 
clear. 
In English and Welsh prisons, the provision of screening and treatment was improved through the 
Counselling, Assessment, Referral, Advice and Throughcare (CARAT) teams and, in England, the 
Integrated Drug Treatment System (IDTS), which expanded the provision of opioid substitution 
therapy (OST) in prisons. Although CARAT teams and the IDTS are no longer centrally supported, the 
legacy of multi-agency working continues. NHS England’s service specifications (NHS-E, 2018) 
explicitly call for a joint, multi-disciplinary approach to the screening, assessment and provision of 
                                                          




services for substance misuse, using a range of services that are equivalent to those used in the 
community.10 The provision of ‘opt-out’ testing for blood-borne viruses (BBVs) has increased uptake 
and the possibility to provide effective treatment in prison (PHE, 2018b).  
The bulk of initiatives described thus far were developed primarily to support people who use 
opioids. As a substantial body of evidence suggests (for example, ACMD, 2013; HM Government, 
2017), this group may have different needs and outcomes to people with other drugs of 
dependence. In this context, it is important to note that custody-community transitions for prisoners 
leaving abstinence-focused interventions (such as Therapeutic Communities, Forward Trust 
programmes, and some pilot drug recovery wings) have received very little attention in either policy 
and/or research. Whilst evidence from the USA suggests that residential aftercare can greatly 
improve the treatment outcomes of this group (Olson & Rozhon, 2011), further UK research is 
needed to understand the particular situation of this group who may be at particular risk of relapse 
following release, and who are currently confronted by a ‘cliff-edge of support’ on release (Lloyd et 
al., 2017). This applies to users of drugs other than heroin as well as to people who have become 
abstinent from heroin in prison and wish to remain so on release. 
Despite considerable progress, many organisations have reported severe problems in prisons in 
recent years. These problems are experienced particularly acutely by people who have problems 
with drugs. Within the remit of this report, significant problems still occur at transitions between 
custody and community, as noted above. 
 
New recommendations 
The ACMD recognises that a large number of recommendations have been made in this field and 
that there are various government commitments on taking action on custody-community 
transitions. This report has therefore focused its recommendations on systemic and practical issues, 
which will improve the implementation of existing and future recommendations. Existing 
recommendations can be seen in the reports listed in Appendix 2. Additional recommendations are 
bound to be made in future by similar agencies. There needs to be a process in place for 
implementing and reviewing such recommendations.  
As the Drug Strategy Board was established to oversee the delivery of the Drug Strategy (HM 
Government, 2017) and drive action across Government and its partners, the ACMD has targeted 




1. That the Drug Strategy Board nominates one Minister who will have over-arching 
responsibility and accountability for the improvement of custody-community transitions 
for prisoners with complex health needs, including problems with drugs. 
                                                          
10 The Custody-Community Transitions working group did receive evidence on ongoing problems with these 
specifications, including a lack of clarity about which agency is responsible for providing and paying for 
naloxone for released prisoners. A potential disparity between advice on how decisions are taken on the 
length of time that patients should receive opioid substitution therapy was also reported between two 




The rationale for this recommendation is that there are many recommendations that relate to 
custody-community transitions that had previously been accepted as necessary but have still not 
been implemented. For example, continuity of care from custody to release is still far below the level 
required to support effective rehabilitation and desistance from problematic drug use and offending. 
The proportion of people leaving prison with no stable accommodation is still too high. The 
proportion of people who have problems with opioids who leave prison with naloxone is far below 
what is needed to protect against death by overdose. Responsibility for implementing such 
recommendations is currently shared among a wide range of bodies below ministerial level, and 
progress requires cross-departmental action. The previous Prisons Minister took personal 
responsibility for reducing violence in ten prisons. It is the ACMD’s view that lead ministerial 
responsibility is required to ensure that previously recommended improvements are delivered to 
improve custody-community transitions. 
2. That this Minister be given the following mandate: To assess and improve performance in 
delivering officially accepted recommendations on transitions between custody and 
community for people with substance misuse, mental health and homelessness problems. 
The indicators of progress in this area should include the following. 
a. Reducing the rate of reoffending (within six months and after two years) of people 
who leave prison and who have an assessed need for drug treatment. 
b. Reducing the numbers of people who die within four weeks of leaving custody 
(separated by police and prison custody) and while under the supervision of the 
probation services. These data should be collated separately for suicides and drug-
related deaths, following the definitions that the Office for National Statistics uses 
for the general population. 
c. Reducing the proportion of people who leave prison with unsettled or unknown 
accommodation on the first night of release. 
d. Increasing the proportion of people who have an assessed need for drug 
treatment on release who enter treatment in the community within four weeks of 
release. 
e. Increasing the proportion of prisoners who are assessed as having a problem with 
opioids who leave prison with naloxone. 
The indicators listed here relate to the key aims of the criminal justice and health systems: to reduce 
reoffending and to protect public health. Previous recommendations – particularly on assuring 
continuity of care and addressing the complex needs of people with substance use problems – will 
have the effect of reducing reoffending and damage to health, of which a key indicator is the level of 
mortality among released prisoners. The data on deaths after prison and police custody are already 
collected in Scotland as part of the Quality Improvement & Outcome Framework (Police Care 
Network, 2015).  The evidence submitted to the ACMD supports the importance of providing stable 
accommodation and continuity of treatment on release. The evidence also supports the 
effectiveness of providing take-home naloxone in reducing deaths. Reflection on these indicators 
should be included in the evaluation of the current drug strategy. 
3. That the Minister of Justice (England and Wales), the Cabinet Secretary for Justice 
(Scotland) and their counterpart in Northern Ireland take further steps to reduce the 
number of transitions into and out of prisons, especially as multiple short sentences are 
associated with increased risk of death. This should involve: 
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a. reform sentencing to minimise the use of sentences of less than 12 months, with 
the aim of eliminating the use in sentencing of periods of less than 3 months in 
prison; and, 
b. reforms to the system of supervision on licence, so as to reduce the number of 
people who are recalled to prison. 
 
The evidence submitted to the ACMD shows that transitions between custody and community are 
inherently risky. People with drug problems are particularly likely to experience such transitions, as 
they are frequently given short prison sentences for repeated acquisitive offences and are often 
recalled to prison from probation supervision in the community due to breaches of conditions. These 
transitions damage continuity of care, and so increase the potential for reoffending and relapse to 
problematic drug use. Short prison sentences are less effective than community penalties in 
reducing reoffending. The improved effect of court orders compared to short prison sentences 
increases for people with multiple previous offences (Hillier & Mews, 2018). Multiple short 
sentences are also linked to higher mortality (Graham et al., 2015). Community penalties are also 
substantially cheaper than prison sentences (Justice Select Committee, 2018). Therefore, this report 
recommends that these two further steps (reforming sentencing and supervision on licence) are 
taken to reduce the use of short periods in prison, which account for a large proportion of the 
transitions between custody and community (both through short sentences and recalls on licence). 
These offenders can be dealt with more effectively in the community, and this should be a main aim 
of the planned reforms to probation. 
 
The Secretary of State for Justice has stated that there is too much use of short sentences (Gauke, 
2018). However, existing measures to reduce the use of these sentences in England (including 
Liaison and Diversion schemes and community sentence treatment requirements [CSTRs]) have not 
substantially reduced the numbers of short sentences that are given.11.  The number of drug 
rehabilitation requirements commenced under a community order or suspended sentence order in 
England and Wales fell from 13,617 in 2011 to 8,719 in 2017 (MoJ contribution, 2018). 
 
CSTRs are more effective than short prison sentences in cutting reoffending (MoJ contribution; also 
PHE, 2017; MoJ, 2018d). However, changes to court and probation services, and ongoing cuts to 
funding for drug treatment services through the public health grant are limiting sentencers’ use of 
such requirements (CJJI, 2018). In some cases, courts would like to make such orders but cannot due 
to a lack of available treatment options (Stacey, 2019). There is also a risk that increased use of 
CSTRs (and of Scottish Drug Treatment and Testing Orders) can lead to ‘net-widening’; bringing more 
people into more intense supervision from the criminal justice system by applying more demanding 
sentences to people who would not otherwise have gone to prison (Malloch & McIvor, 2013). The 
CSTR protocol pilots that were jointly run by the MoJ, DHSC, NHS England and PHE provide valuable 
lessons on how to improve the use of CSTRs.   
 
Under the Criminal Justice and Licensing (Scotland) Act 2010, the Scottish Government introduced a 
presumption against custodial sentences of less than three months. This has had some effect in 
reducing the shortest sentences, but 3,495 people received a sentence of less than 3 months in 
Scotland in 2016/17 (Scottish Government, 2018a). The Scottish Government is now considering 
strengthening this presumption and extending it to reduce the use of sentences under 12 months. 
                                                          





When prisoners are released under licence to the supervision of the NPS or CRCs, they can be 
recalled to prison for breaching conditions of their licence. In the year 2017/18, there were 22,183 
licence recalls to prisons in England and Wales. This is an increase of 27% since 2013/14. These 
recalls increase the number of transitions between custody and community. As noted above, these 
transitions increase the risk of health problems and often break continuity of care. They also create 
an opportunity to smuggle substances, including synthetic cannabinoids, into prison. A 2018 
thematic inspection on enforcement and recall by Her Majesty’s Inspectorate of Probation (HMI 
Probation, 2018) found that:  
• post-custodial supervision by CRCs was poor;  
• CRCs were ‘stretched beyond their capacity’; and,  
• enforcement had the effect of compounding rather than lessening the sense of a 
revolving door between prison and the community.  
The HMI Probation recommended that the Government “should ensure that probation services are 
sufficiently resourced to supervise individuals with complex needs [including people with substance 
misuse problems] effectively” and that Her Majesty’s Prison and Probation Service (HMPPS) “should 
set expectations that CRCs and the NPS develop partnership-based approaches with key local 
stakeholders to manage those released from prison on licence” (ibid.). The ACMD supports these 
recommendations. HMI Probation has also recently recommended that the Ministry of Justice 
‘review the suitability of the sanctions available for breaches of post-sentence supervision (PSS) and 
consider alternatives that enhance the purpose of rehabilitation’ (HMI Probation, 2019).  
 
In England and Wales particularly, a more radical approach is needed to succeed in reducing the use 
of short sentences, as was recognised by the former Prisons Minister.12 This report therefore 
recommends that the Justice Secretary aligns policy in England and Wales with the Scottish 
Government’s intention to substantially reduce the use of custodial sentences of less than 12 
months. This will require legislative change, reforms to sentencing guidance, and robust steps to 
improve the confidence of the courts in the quality and safety of supervision on community 




In support of the systemic recommendations made above, and by others in the field, this report 
makes the following practical recommendations. 
4. That the prison services of the UK take steps to minimise the release of prisoners with 
complex needs (including substance misuse) on Friday afternoons. 
Between January and June 2018, 11,080 people were released on a Friday from prisons in England 
and Wales.13 As prisoners with release dates on Saturdays, Sundays or a bank holiday Monday are 
released on Fridays, more than a third of prisoners are released on Fridays. In the working group’s 
evidence gathering were several reports that release on a Friday – especially when that release is 
late in the day – makes it difficult to access stable housing, drug treatment, and connections with 







probations services and job centres. People often have to attend several appointments on their first 
day of release. If these appointments are missed on a Friday, then the person may be left for the 
weekend with no housing, no money and no drug treatment. These are circumstances in which 
relapse to drug use and offending are highly likely to occur. These issues have also been highlighted 
by the National Association for the Care and Resettlement of Offenders charity (NACRO, 2018). 
 
5. That the Department for Work and Pensions (DWP) should: 
a. accelerate the introduction of the measures listed in the 2018 Rough Sleeping 
Strategy (MHCLG, 2018) to enable prisoners to access employment or Universal 
Credit immediately on release; 
The Rough Sleeping Strategy committed the DWP to the following measures:  
• increasing the level of prisoner engagement with Prison Work Coaches;  
• supporting prisoners to begin the Universal Credit claim in prison;  
• continuing work to support prisoners to open bank accounts in prison; and,  
• supporting prisoners to verify their identity for Universal Credit purposes.  
 
b. work in partnership with Her Majesty’s Courts and Tribunal Services (HMCTS) and 
the NPS to ensure that people who are imprisoned are not overpaid the housing 
element of Universal Credit; and, 
c. Following the completion of the evaluation of the pilots, implement the effective 
elements identified through evaluation.  
 
Several contributors to the working group’s evidence gathering commented on the difficulties faced 
in accessing accommodation and money to live on after release from prison. This is particularly 
problematic for people who have drug problems, as was also identified in Lord Patel’s report (Patel, 
2010). Some also commented on the difficulties faced by people who have their Universal Credit 
payments reduced due to overpayments that occur when the housing element is paid while the 
claimant is in prison.  
 
The DWP informed the working group that similar measures had been piloted at Her Majesty’s 
Prisons (HMPs) Wayland, Norwich and Belmarsh. This report recommends that – following the 
currently ongoing evaluation of these pilots – the effective elements of this approach be rolled out 
quickly to other prisons. 
 
6. That the prison and probation services of the UK should develop and extend services that 
provide face-to-face, individualised support to prisoners who have drug problems in the 
run up to release and through the transition to the community.  
The ACMD asked respondents to its call for evidence to identify elements of good practice in 
reducing harms related to custody-community transitions. The features listed in this 
recommendation are the common elements of the examples of good practice reported by these 
respondents. They fit with the wider body of evidence that suggests that the most effective services 
offer holistic support and create good rapport between professionals and people who wish to desist 
from crime and problematic substance use (Sapouna, Bisset, & Conlong, 2011). They also align with 
recent guidance (PHE, 2018c) to increase the use of ‘in-reach’ services to improve the continuity of 
care between custody and the community. These services should include connecting people with 
mutual aid groups that can support them on release. They should also include the establishment of 
stronger links with substance misuse specialist supported housing programmes, where these exist. 
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7. That the Drug Strategy Board should make a clear statement that it is the responsibility of 
the national NHS bodies to ensure that all people who have an assessed problem with 
opioid use should be given the opportunity to take home naloxone when they leave prison 
or police custody. The Board should ensure that resources are made available to the 
national NHS bodies to support this responsibility. 
 
In 2011, Scotland launched a centrally funded National Naloxone Programme, designed to increase 
the provision of naloxone to prisoners who needed it before their release across the Scottish prison 
estate (Horsburgh & McAuley, 2017). An evaluation showed a 60% reduction in the proportion of 
opioid-related deaths that occurred within 4 weeks of prison-release (from 10% to 4%) (Bird et al., 
2017). Naloxone provision to prisoners on release from prisons in Wales is also nationally funded. 
The English N-ALIVE randomised trial showed that it was also feasible to provide naloxone in English 
prisons. Released prisoners more often use naloxone to reverse overdoses that are experienced by 
others, rather than themselves (Parmar et al., 2017). This suggests a potential diffusion of benefit 
from providing naloxone pre-release in preventing overdose deaths in the community.  
The Scottish experience has provided a number of useful operational lessons for maximising the 
potential of naloxone to save lives on release from prison. This includes, for example, ensuring that a 
naloxone kit is placed in a prisoner’s valuables before their release date so that the person does not 
have to wait for a kit to be delivered to them on that day (Horsburgh, 2018). The bulkiness of the kit 
has been a barrier to people carrying it for when they might need to use it, but different 
formulations and more compact intra-nasal kits that have recently become available offer the 
potential to increase the life-saving use of naloxone (Bird & McAuley, 2019).  
8. That relevant agencies (for example, PHE) establish custody-community pathways into 
identified treatment for prisoners who have an assessed problem with alcohol, cannabis, 
cocaine, or other non-opioid drugs – as well as for users of opioids. Additionally, that a 
pathway should be developed that offers sufficient support to enable prisoners leaving 
abstinence-focused interventions to maintain such change following release. 
The experience of the drug recovery wing pilots suggests that existing services in England do not 
provide sufficient responses to the needs of people who have problems with substances other than 
opioids. It also suggests that the benefits of abstinence-focused interventions in prisons are often 
lost when people are released (Lloyd et al., 2017). Therefore, the ACMD recommends that post-
release pathways for people with non-opioid problems and for people who have achieved 
abstinence in prison be strengthened. This could include reference to the Drug, Alcohol and 
Tobacco Health Services in Scottish Prisons: Guidance for Quality Health Service Delivery (NHS 
Scotland, 2016) and the police care network’s guideline for substance misuse in police custody 
(Police Care Network, 2015). 
9. That the Home Office should commission research specifically to identify and ameliorate 
problems and opportunities related to transitions into and out of police custody by people 
who have problems with drugs. This should include gathering information, across the UK, 
on: 
a. the levels of overdose and drug-related deaths in police custody and immediately 
afterwards; and, 
b. the coverage and effectiveness of Liaison and Diversion schemes in meeting the 
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Appendix 1 – Stakeholder engagement and Quality of Evidence 
The Custody-Community Transitions working group wrote to stakeholders requesting written or oral 
submissions. Written evidence was received from the following: 
• Adfam 
• the Association of Police and Crime Commissioners (APCC) 
• Blenheim 
• Changing Lives 
• Clinks 
• Collective Voice 
• the Care Quality Commission (CQC) 
• Essex County Council 
• Forward 
• HM Inspectorate of Prisons (HMIP) 
• HM Inspectorate of Probation (HMI Probation) 
• Humankind 
• Indivior  
• INQUEST 
• Manchester Metropolitan University 
• Ministry of Justice (MoJ) and HM Prison and Probation Service (HMPPS) 
• Newcastle University 
• NHS England 
• Phoenix Futures 
• Police and Crime Commissioner (PCC) North Wales 
• Positive Prison, Positive Futures 
• Release 
• West Yorkshire Police 
 
Oral Evidence was received from the following at the evidence gathering day: 
• Vivienne Evans – Adfam 
• John Jolly – Blenheim 
• Paul Hayes – Collective Voice 
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• Hattie Moyes – Forward Trust 
• Rob Ralphs – Manchester Metropolitan University 
• Ministry of Justice (MoJ) and Her Majesty's Prison and Probation Service (HMPPS) 
• Kate Davies – NHS England 
• Karen Biggs – Phoenix Futures 
• Nino Maddalena and Alicia Cooper – Public Health England (PHE) 
This report also draws on evidence from peer reviewed literature, independent report, and policy 
evaluations. The majority of evidence used was from the UK but some international examples are 
referred to. Evidence gathered was considered in line the ACMD’s SOP for quality of evidence.   
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Appendix 3 – List of abbreviations used in this report  
ACMD Advisory Council on the Misuse of Drugs 
BBV Blood borne virus 
CARAT Counselling, Assessment, Referral, Advice and Throughcare 
CCT Custody-community transition 
CJJI Criminal Justice Joint Inspectorates 
CRCs Community Rehabilitation Companies 
CSTR Community sentence treatment requirements 
DH Department of Health  
DHSC Department of Health and Social Care 
DIP Drug Interventions Programme 
DSB Drug Strategy Board 
DWP Department for Work and Pensions 
EPRA Ex-Prisoners Recovering from Addiction  
HMCTS Her Majesty's Courts and Tribunals Service 
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HMIP Her Majesty's Inspectorate of Prisons 
HMI Probation Her Majesty's Inspectorate of Probation 
HMPPS Her Majesty's Prison and Probation Service 
IDTS Integrated Drug Treatment System 
ISD Information Services Division (Scotland) 
L+D Liaison and Diversion 
MHCLG Ministry of Housing, Communities and Local Government 
MMU Manchester Metropolitan University  
MoJ Ministry of Justice 
NACRO National Association for the Care and Resettlement of Offenders 
NHS National Health Service  
NPS National Probation Service 
OST Opioid substitution therapy 
PHE Public Health England 
PSS Post-sentence supervision  
THN Take-Home Naloxone 
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